Wolff-Parkinson-White Syndrome: ECG Findings and Management
Wolff-Parkinson-White (WPW) syndrome is diagnosed by three characteristic ECG findings: a short PR interval (<120 ms), a delta wave (slurred upstroke of the QRS), and a widened QRS complex (>120 ms), with secondary ST-T wave changes typically discordant to the delta wave. 1
Characteristic ECG Features
The classic WPW pattern results from ventricular pre-excitation via an accessory pathway that bypasses the AV node:
- PR interval <0.12 seconds - reflects early ventricular activation
- Delta wave - slurred initial QRS segment from pre-excitation
- QRS duration >0.12 seconds - widened from abnormal depolarization
- Secondary repolarization abnormalities - ST-T wave changes directed opposite to the delta wave 1, 2
Critical caveat: Not all patients show classic pre-excitation on every ECG. The degree of pre-excitation varies depending on accessory pathway properties, location, and autonomic tone. Serial ECGs may be necessary to capture the diagnostic pattern 3.
Risk Stratification: Who Needs Urgent Intervention?
High-risk features predicting sudden cardiac death:
- Shortest pre-excited R-R interval <250 ms during atrial fibrillation 4, 5
- History of syncope (suggests rapid ventricular rates) 5
- Multiple accessory pathways 4
- Symptomatic tachyarrhythmias 4
The risk of sudden death is 0-0.6% per year, but notably higher in children than adults, with sudden death sometimes being the first presentation 4, 6.
Management Algorithm
Acute Management of Pre-Excited Atrial Fibrillation
If hemodynamically unstable:
- Immediate electrical cardioversion - this is Class I recommendation to prevent degeneration to ventricular fibrillation 5, 7
If hemodynamically stable with wide QRS (≥120 ms):
ABSOLUTELY CONTRAINDICATED in pre-excited AF:
- AV nodal blocking agents are potentially harmful - this includes adenosine, digoxin, diltiazem, verapamil, beta-blockers, and amiodarone 5
- These drugs block the AV node, forcing preferential conduction down the accessory pathway, which can accelerate ventricular rate and precipitate ventricular fibrillation 4
Acute Management of Orthodromic AVRT (Narrow Complex)
For the more common narrow-complex tachycardia:
- Vagal maneuvers first 9
- Adenosine - safe when QRS <120 ms, indicating conduction through AV node 4
- Synchronized cardioversion if pharmacologic therapy fails 9
Definitive Management
Catheter ablation is the Class I recommendation for:
- All symptomatic patients with WPW syndrome 5, 8
- Particularly those with syncope, documented AF, or short bypass tract refractory period (<250 ms) 4, 7
- Success rates exceed 90%, though recurrence occurs in approximately 24% 10
Important limitation: Ablation eliminates the accessory pathway but doesn't necessarily prevent AF, especially in older patients - additional antiarrhythmic therapy may still be needed 4.
Asymptomatic Patients
The 2014 AHA/ACC/HRS guidelines 5 recommend catheter ablation even for asymptomatic patients if electrophysiologic study demonstrates a pathway capable of rapid anterograde conduction. This is particularly important in children, where the risk of sudden death as the first presentation is substantially higher than in adults 10, 11.
All patients with WPW pattern on ECG should undergo electrophysiologic study for risk stratification 10. The finding that VF can be induced in asymptomatic patients during EP study (2 of 109 patients in one pediatric series) underscores that WPW is not benign 10.
Common Pitfalls to Avoid
- Never give AV nodal blockers for wide-complex irregular tachycardia - assume pre-excited AF until proven otherwise
- Don't rely on a single normal ECG - pre-excitation may be intermittent 3
- Don't assume asymptomatic = low risk - sudden death can be the first manifestation, especially in young patients 6, 10
- Don't confuse antidromic AVRT with ventricular tachycardia - both present as wide-complex regular tachycardia, but treatment differs dramatically 3
The key to preventing mortality is early identification, proper risk stratification through electrophysiologic study, and definitive treatment with catheter ablation in appropriate candidates 5, 2.